Axovant Sciences Ltd.
Clarendon House
2 Church Street
Hamilton
HM 11
Website: http://www.axovant.com/
Email: info@axovant.com
121 articles about Axovant Sciences Ltd.
-
Axovant Announces Pricing Of $125M Public Offering Of Common Shares
4/11/2017
-
Axovant Announces $100 Million Public Offering Of Common Shares
4/11/2017
-
And He's Back! Medivation's David Hung to Helm Vivek Ramaswamy's Axovant
4/11/2017
-
Axovant Announces Dementia Pipeline Updates And Reports Financial Results For The Third Fiscal Quarter And Nine Months Ended December 31, 2016
2/15/2017
-
Axovant Clears an Early Hurdle in Mid-Stage Dementia Trial, But Questions Remain
2/13/2017
-
H. Lundbeck A/S Throws in the Towel on Alzheimer's Pill, Giving Leeway to Rival Axovant
2/8/2017
-
31-Year-Old Biotech Guru Brings in Another $55 Million for Axovant
2/6/2017
-
Axovant Unveils New Data Analysis Showing Addition Of Intepirdine To Standard Therapy May Help People With Alzheimer's Disease Maintain Independence Longer
12/12/2016
-
The Small-Cap Biotech That Could Take Down Biogen, Celgene, Eli Lilly and Gilead in Alzheimer's
11/9/2016
-
Axovant Announces Dementia Pipeline Updates And Reports Financial Results For The Second Fiscal Quarter And First Half Ended September 30, 2016
11/9/2016
-
Axovant Announces Dementia Pipeline Updates And Reports Financial Results For The Second Fiscal Quarter And First Half Ended September 30, 2016
11/8/2016
-
Axovant Receives FDA Fast-Track Designation For Intepirdine As An Investigational Treatment For Dementia With Lewy Bodies
9/26/2016
-
Axovant To Present At The Morgan Stanley Global Healthcare Conference
9/7/2016
-
Axovant Sciences To Present At The Baird 2016 Global Healthcare Conference
9/1/2016
-
Axovant Announces Expansion Of Dementia Pipeline And Reports Financial Results For The First Fiscal Quarter Ended June 30, 2016
8/16/2016
-
Axovant Release: Alzheimer's Experts Call For End To Under-Treatment Of Disease
7/25/2016
-
Axovant Announces Presentations And Sponsored Symposium At The 2016 Alzheimer's Association International Conference
7/19/2016
-
Axovant To Present At The JMP Securities Life Sciences Conference
6/16/2016
-
Axovant Announces 2015 Fiscal Year-End Financial Results And Corporate Updates
6/6/2016
-
Axovant Appoints Dr. Gary P. Pisano To Board Of Directors
5/13/2016